See unlike you I hold college degrees, one is in statistical policy analysis and you? A sixth grade drop out so lets clear that up first.
He's wrong with his randomized study premise. If only randomized studies were accurate and the gold standard why do research institutions and medical institutes and thousands of other think tanks use all types of statistical studies? Guess what else? Randomized studies can also be biased and manipulated. In his response he is actually doing what he accuses non randomized studies of doing. He talks about a higher incidence of cancer. What type of cancer? How long ago did the control group he is pointing out have cancer and how were they treated? Where they squamish cell carcinomas that were removed 40 years ago or is a patient with stage 4 bronchial cancer who is having radiation and/or chemotherapy now? In any studies there are a multitude of variables and in all studies you try and adjust for them. In any study the study is only as good as the data. His premise is only randomized studies, about 5 of them are the only studies that matter. Nothing is further than the truth. You don't have to have a randomized study to find efficacy. The NIH and Dr. Fauci himself have released plenty of studies of efficacy that weren't randomized.
BTW: this guy works for the NIH so his grants and career depend on what he says.
Dr. Fauci was appointed director of NIAID in 1984. He oversees an extensive portfolio of basic and applied research to prevent, diagnose, and treat established infectious diseases such as HIV/AIDS, respiratory infections, diarrheal diseases, tuberculosis and malaria as well as emerging diseases...www.niaid.nih.gov
See where it says "we estimate"????
Since the beginning of 2018, the United States has undertaken unprecedented tariff increases, with one goal of these actions being to boost the manufacturing sector. In this paper, we estimate the effect of the tariffs—including retaliatory tariffs by U.S. trading partners—on manufacturing employment, output, and producer prices. A key feature of our analysis is accounting for the multiple ways that tariffs might affect the manufacturing sector, including providing protection for domestic industries, raising costs for imported inputs, and harming competitiveness in overseas markets due to retaliatory tariffs. We find that U.S. manufacturing industries more exposed to tariff increases experience relative reductions in employment as a positive effect from import protection is offset by larger negative effects from rising input costs and retaliatory tariffs. Higher tariffs are also associated with relative increases in producer prices via rising input costs.